Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Cancer
|
June 22, 2011
Impact of race on biochemical disease recurrence after prostate brachytherapy
Kosj Yamoah, Nelson Stone, Richard Stock
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality
Marisa A Kollmeier, Richard G Stock, Nelson Stone
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2011
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer
Kevin Forsythe, Seth Blacksburg, Nelson Stone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 6, 2011
Predictors of metastatic disease after prostate brachytherapy
Kevin Forsythe, Ryan Burri, Nelson Stone, et al.
BJUI Compass
|
April 27, 2022
Transperineal prostate biopsy identifies locations of clinically significant prostate cancer in men considering focal therapy with PI-RADS 3-5 regions of interest
Nelson Stone, Vassilios Skouteris, Samuel Chang, et al.
Brachytherapy
|
August 1, 2018
Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy
Lucas Resende Salgado, Ryan Rhome, William Oh, et al.
Brachytherapy
|
October 17, 2016
The impact of timing of salvage hormonal therapy on survival after brachytherapy for prostate cancer
Daniel Sagalovich, Michael Leapman, John Sfakianos, et al.
Pathology, Research and Practice
|
August 4, 2009
Histological patterns and associated PSA levels for prostatic adenocarcinoma following brachytherapy
Guang-Qian Xiao, Youming Huan, Nelson Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study
Anna C Ferrari, Nelson Stone, Richard Stock, et al.
The Journal of Urology
|
July 28, 2011
Methods of developing UWIN, the modified American Urological Association symptom score
Al B Barqawi, Kathryn F Sullivan, E David Crawford, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Cancer
|
June 22, 2011
Impact of race on biochemical disease recurrence after prostate brachytherapy
Kosj Yamoah, Nelson Stone, Richard Stock
International Journal of Radiation Oncology, Biology, Physics
|
October 8, 2003
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality
Marisa A Kollmeier, Richard G Stock, Nelson Stone
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2011
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer
Kevin Forsythe, Seth Blacksburg, Nelson Stone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 6, 2011
Predictors of metastatic disease after prostate brachytherapy
Kevin Forsythe, Ryan Burri, Nelson Stone, et al.
BJUI Compass
|
April 27, 2022
Transperineal prostate biopsy identifies locations of clinically significant prostate cancer in men considering focal therapy with PI-RADS 3-5 regions of interest
Nelson Stone, Vassilios Skouteris, Samuel Chang, et al.
Brachytherapy
|
August 1, 2018
Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy
Lucas Resende Salgado, Ryan Rhome, William Oh, et al.
Brachytherapy
|
October 17, 2016
The impact of timing of salvage hormonal therapy on survival after brachytherapy for prostate cancer
Daniel Sagalovich, Michael Leapman, John Sfakianos, et al.
Pathology, Research and Practice
|
August 4, 2009
Histological patterns and associated PSA levels for prostatic adenocarcinoma following brachytherapy
Guang-Qian Xiao, Youming Huan, Nelson Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study
Anna C Ferrari, Nelson Stone, Richard Stock, et al.
The Journal of Urology
|
July 28, 2011
Methods of developing UWIN, the modified American Urological Association symptom score
Al B Barqawi, Kathryn F Sullivan, E David Crawford, et al.
Page
of 2